期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

子宫浆液性腺癌的研究进展 被引量：2

下载PDF
导出
摘要 子宫浆液性腺癌（uterineserouscarcinoma，USC）以往称为“子宫乳头状浆液性癌”（uterinepapillaryserouscarcinoma，UPSC）。随后病理学家发现．UPSC的结构有一定多样性，除了典型的分支乳头状结构，还可表现为腺管状结构，无论以腺管状或乳头状结构为主，生物学行为均相同；另外，UPSC存在核形态学（核分级高）与结构（分化良好的乳头状或腺管状结构）的不一致。
作者 郑泽纯 李小毛
机构地区 中山大学附属第三医院妇产科
出处 《实用医学杂志》 CAS 北大核心 2014年第2期188-189,共2页 The Journal of Practical Medicine
基金 国家自然科学基金(编号:30772332) 广东省科技计划项目(编号:2010B031600035) 广东省妇幼安康工程-子宫内膜癌防治项目
关键词 子宫乳头状浆液性癌 浆液性腺癌 乳头状结构 腺管状结构 UPSC 生物学行为 病理学家 核形态学
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1廖晓耘,王恩杰,吕晓红,李荣,沈丹华.子宫浆液性癌及内膜上皮内癌临床病理分析[J].临床与实验病理学杂志,2006,22(1):36-41. 被引量：4
  • 2Roelofsen T,van Ham MA,de Hullu JA. Clinical management of uterine papillary serous carcinoma[J].{H}EXPERT REVIEW OF ANTICANCER THERAPY,2011,(01):71-81. 被引量：1
  • 3杨越波;李小毛;向阳.子宫肿瘤[M]{H}北京:人民军医出版社,2012468-469. 被引量：1
  • 4Fader AN,Boruta D,Olawaiye AB. Uterine papillary serous carcinoma:epidemiology,pathogenesis and management[J].{H}Current Opinion in Obstetrics & Gynecology,2010,(01):21-29. 被引量：1
  • 5Moore KN,Fader AN. Uterine papillary serous carcinoma[J].{H}CLINICAL OBSTETRICS AND GYNECOLOGY,2011,(02):278-291. 被引量：1
  • 6Tergas AI,Buell-Gutbrod R,Gwin K. Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure[J].{H}Gynecologic Oncology,2012,(02):316-320. 被引量：1
  • 7Lavie O,Ben-Arie A,Segev Y. BRCA germline mutations in women with uterine serous carcinoma--still a debate[J].{H}International Journal of Gynecological Cancer,2010,(09):1531-1534. 被引量：1
  • 8Ambros RA,Sherman ME,Zahn CM. Endometrial intraepithelial carcinoma:a distinctive lesion specifically associated with tumors displaying serous differentiation[J].{H}Human Pathology,1995,(11):1260-1267. 被引量：1
  • 9Pathiraja P,Dhar S,Haldar K. Serous endometrial intraepithelial carcinoma:a case series and literature review[J].Cancer Manag Res,2013.117-122. 被引量：1
  • 10Yi X,Zheng W. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia[J].{H}Current Opinion in Obstetrics & Gynecology,2008,(01):20-25. 被引量：1

二级参考文献13

  • 1郭丽娜,刘彤华.子宫内膜浆液性腺癌[J].中华病理学杂志,1994,23(1):23-25. 被引量：4
  • 2Sherman M E,Bitterman P,Rosenshein N B,et al.Uterine serous carcinoma,a morphologicallydiverse neoplasm with unifying clinicopathologic features[J].Am J SurgPathol,1992,16(6):600-610. 被引量：1
  • 3Ambros R A,Sherman M E,Zahn C M,et al.Endometrial intraepithelial carcinoma:adistinctive lesion specifically associated with tumors displaying serousdifferentiation[J].Hum Pathol,1995,26(11):1260-1267. 被引量：1
  • 4Spiegel G W.Endometrial carcinoma in situ in postmenopausal women[J].Am J SurgPathol,1995,19(4):417-432. 被引量：1
  • 5Zheng W,Khurana R,Farahmand S,et al.p53 immunostaining as a significant adjunctdiagnostic method for uterine surface carcinoma:precursor of uterine papillary serouscarcinoma[J].Am J Surg Pathol,1998,22(12):1463-1473. 被引量：1
  • 6Soslow R A,Pirog E,Isacson C.Endometrial intraepithelial carcinoma with associatedperitoneal carcinomatosis[J].Am J Surg Pathol,2000,24(5):726-732. 被引量：1
  • 7Baergen R N,Warren C D,Isacson C,et al.Early uterine serous carcinoma:clonal origin ofextrauterine disease[J].Int J Gynecol Pathol,2001,20(3):214-219. 被引量：1
  • 8Wheeler D T,Bell K A,Kurman R J,et al.Minimal uterine serous carcinoma,diagnosis andclinicopathologic correlation[J].Am J Surg Pathol,2000,24(6):797-806. 被引量：1
  • 9Tashiro H,Isacson C,Levine R,et al.p53 gene mutations are common in uterine serouscarcinoma and occur early in their pathogenesis[J].Am J Surg Pathol,1997,150(1):177-185. 被引量：1
  • 10Ronnett B M,Kurman R J.Precursor lesions of endometrial carcinoma[M]//KurmanRJ,ed.Blaustein's pathology of the female genital tract.5th ed.NewYork:Springer,2002:467-500. 被引量：1

共引文献3

同被引文献25

  • 1Roelofsen T, Van Ham MA, De Hullu JA, et al. Clinical manage- ment of uterine papillary serous carcinoma[ J ]. Expert Rev Antican- cer Ther,2011,11 ( 1 ) :71-81. 被引量：1
  • 2Del Carmen MG, Birrer M, Schorge JO. Uterine papillary serous canc- er: A review of the litemture [ J ]. Gynecol Oncol, 2012, 127 ( 3 ) : 651-661. 被引量：1
  • 3Fader AN, Boruta D, Olawaiye AB, et al. Uterine papillary serous car- cinoma : epidemiology, pathogenesis and management [ J ]. Curr Opin Obstet Gynecol,2010,22( 1 ) :21-29. 被引量：1
  • 4Moore KN, Fader AN. Uterine papillary serous carcinoma [ J ]. Clin Obstet Gynecol,2011,54(2) :278-291. 被引量：1
  • 5Tergas AI, Buell-Gutbrod R, Gwin K, et al. Clinico-pathologic com- parison of type I1 endometrial cancers based on tamoxifen exposure [ J ]. Gynecol Onco1,2012,127 ( 2 ) :316-320. 被引量：1
  • 6Lavie O, Ben-Arie A, Segev Y, et al. BRCA germline mutations in women with uterine serous carcinoma-still a debate[ J]. Int J Gynecol Cancer,2010,20 (9) :1531-1534. 被引量：1
  • 7Giuntoli RN, Gerardi MA, Yemelyanova AV, et al. Stage I noninva- sire and minimally invasive uterine serous carcinoma:comprehensive staging associated with improved survival [ J ]. Int J Gynecol Cancer, 2012,22(2) :273-279. 被引量：1
  • 8Chan JK, Loizzi V, Youssef M, et al. Significance of comprehensive surgical staing in noninvasive papillary serous carcinoma of the en-dometrium[ J]. Gynecol Oncol, 2003, 90(1 ) :181-185. 被引量：1
  • 9Rauh-Hain JA, Growdon WB, Schorge JO, et al. Prognostic determi- nants in patients with stage C and 1V uterine papillary serous car- cinoma [ J ]. Gynecol Oncol, 2010,119 ( 2 ) :299-304. 被引量：1
  • 10Fader AN, Nagel C, Axtell AE, et al. Stage II uterine papillary serous carcinoma: Carboplatin/ paclitaxel chemotherapy improves recur- rence and survival outcomes[ J ]. Gynecol Oncol, 2009, 112 ( 3 ) : 558 -562. 被引量：1

引证文献2

二级引证文献13

实用医学杂志
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部